Alkermes (ALKS) Other financing activities (2012 - 2026)
Alkermes (ALKS) reported Other financing activities of $15.7 million for Q1 2026, down 46.78% year-over-year from $29.5 million in Q1 2025, and up 40.58% quarter-over-quarter from $11.2 million in Q4 2025.
Alkermes (ALKS) Other financing activities (2012 - 2026) Analysis & Trends
Alkermes (ALKS) has 14 years of Other financing activities data on file, last reported at $15.7 million in Q1 2026.
- Other financing activities for Q1 2026 came in at $15.7 million, down 46.78% year-over-year; the trailing twelve-month figure through Mar 2026 was $29.6 million (down 35.48% YoY), and the FY2025 annual result was $43.4 million, up 57.45% from the prior year.
- Other financing activities grew to $15.7 million in Q1 2026 per ALKS's latest filing, from $11.2 million in the prior quarter.
- Over five years, Other financing activities peaked at $29.5 million in Q1 2025 and troughed at $622000.0 in Q3 2025.
- A 5-year average of $7.2 million and a median of $3.1 million in 2023 frame the typical range for Other financing activities.
- The sharpest annual moves came in 2024 and 2025: Other financing activities jumped 398.97% in 2024, then tumbled 88.73% in 2025.
- A 5-year view of Other financing activities shows it stood at $780000.0 in 2022, then soared by 111.15% to $1.6 million in 2023, then surged by 398.97% to $8.2 million in 2024, then soared by 36.02% to $11.2 million in 2025, then soared by 40.58% to $15.7 million in 2026.
- Business Quant data shows ALKS's Other financing activities at $15.7 million in Q1 2026, $11.2 million in Q4 2025, and $622000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.71 Mn |
| Mar 31, 2026 | 15.71 Mn |
| Dec 31, 2025 | 11.18 Mn |
| Dec 31, 2025 | 11.18 Mn |
| Sep 30, 2025 | 622,000.00 |
| Sep 30, 2025 | 622,000.00 |
| Jun 30, 2025 | 2.08 Mn |
| Jun 30, 2025 | 2.08 Mn |
| Mar 31, 2025 | 29.53 Mn |
| Mar 31, 2025 | 29.53 Mn |
| Dec 31, 2024 | 8.22 Mn |
| Dec 31, 2024 | 8.22 Mn |
| Sep 30, 2024 | 5.52 Mn |
| Sep 30, 2024 | 5.52 Mn |
| Jun 30, 2024 | 2.61 Mn |
| Jun 30, 2024 | 2.61 Mn |
| Mar 31, 2024 | 11.23 Mn |
| Mar 31, 2024 | 11.23 Mn |
| Dec 31, 2023 | 1.65 Mn |
| Dec 31, 2023 | 1.65 Mn |